Uterine Fibroids and Fertility: Which Fibroids Matter Most

Medically reviewed on 19 July 2026 - Dr. Senai Aksoy
Medical illustration of the uterus showing submucosal, intramural, and subserosal fibroid locations

Key Takeaways

Not every fibroid affects fertility the same way; location is the decisive factor. Submucosal fibroids and cavity-distorting lesions are most likely to interfere with implantation and miscarriage risk, while subserosal fibroids usually do not. Whether to remove a fibroid depends on location, symptoms, age, ovarian reserve, and treatment timing.

Key evidence: ASRM guideline on myoma removal to improve fertility (2017) Systematic review: surgical treatment of fibroids for subfertility (Metwally et al., Cochrane 2012) Updated review: fibroids and infertility (Pritts et al., Fertil Steril 2009)

On this page

Uterine fibroids are very common. They are benign growths in the muscle of the uterus. Many women learn they have one by accident — on a routine scan, or when fertility testing begins.

Then the same question arrives, almost word for word: Do I need surgery before I try to get pregnant — or before IVF?

Usually, no. Not every fibroid needs to come out. What matters most is where it sits, what it is doing to the cavity, whether it causes bleeding or pain, and how that fits your timeline. The rest of this page walks through what the evidence actually supports — and where your doctor still has to judge the details of your case.

What are uterine fibroids?

Short answer: Fibroids (leiomyomas) are benign tumours from the uterine muscle. We group them by location: submucosal (into the cavity), intramural (in the wall), or subserosal (outward).

They come in different sizes and numbers. The label that helps fertility planning most is not “fibroid” — it is where the fibroid sits relative to the cavity:

Who might this matter for?

Short answer: Anyone planning a pregnancy who has a fibroid — especially a submucosal or cavity-distorting one, or after recurrent miscarriage or failed implantation.

You may want to read this carefully if you:

This page cannot diagnose you. That needs imaging aimed at the cavity — often 3D ultrasound or a saline scan, sometimes a pelvic MRI.

How fibroids affect fertility and treatment outcomes

Short answer: The clearest link is with submucosal and cavity-distorting fibroids: lower pregnancy rates and higher miscarriage risk in the studies we trust most. Non-distorting intramural fibroids are murkier; experts still disagree.

How might a fibroid get in the way?

In IVF, reviews and guideline work point in one fairly steady direction: removing a submucosal fibroid is more often linked with better clinical pregnancy rates. Removing an intramural fibroid that does not distort the cavity does not show the same consistent gain (Metwally et al., 2012; ASRM Practice Committee, 2017).

What the evidence can — and cannot — prove

Short answer: Strong for submucosal and cavity-distorting fibroids. Mixed for non-distorting intramural ones. Weak for subserosal ones. No large trial settles the perfect surgical timing before IVF for every patient.

ClaimStrength of evidenceImportant notes
Submucosal fibroids reduce pregnancy rates and raise miscarriage riskStrong (systematic reviews, ASRM guidance)Hysteroscopic removal often improves the picture
Non-distorting intramural fibroids reduce IVF successMixedSome papers flag concern above ~4–5 cm; others see little difference
Removing non-distorting intramural fibroids improves IVF outcomesUncertainFew solid RCTs; age, reserve, and calendar matter
Subserosal fibroids affect fertilityWeakRarely the main infertility factor

Studies also disagree on what “cavity distortion” means, and often mix different sizes and locations in one group. That is why two honest doctors can look at the same 4 cm intramural fibroid and still debate surgery.

Evaluation and management options

Short answer: Map the fibroid carefully first. Then weigh benefit against surgical risk and delay — not against the word “fibroid” alone.

Hysteroscopic myomectomy

Usually the first route for submucosal fibroids (especially FIGO types 0 and 1). Often a day case. Risks are relatively low, but real: perforation, bleeding, scarring inside the cavity. When the fibroid truly distorts the cavity, removal is the path most clearly backed by guidance (ASRM, 2017).

Laparoscopic myomectomy

For larger intramural fibroids, or subserosal ones that cause pressure or pain, or that clearly reshape the cavity. The surgeon’s experience matters: adhesions later, and the quality of the uterine repair before a future pregnancy, both depend on it. Many or very large fibroids (often above 8–10 cm), or ones buried deep in the wall, can tip the plan toward open surgery.

Open myomectomy

Still the safer map when fibroids are very large, very numerous, laparoscopy is not the right tool, or a rare malignancy is on the table. Recovery is longer. The scar is larger.

Watching and waiting

Sensible for small, quiet, non-distorting fibroids — especially if ovarian reserve is already low and three to six months of surgery-plus-healing would cost more time than the fibroid is worth.

At a glance: comparing treatment options

Short answer: Typical patterns only. Your case may sit between two columns.

Question or decisionHysteroscopyLaparoscopyOpen surgeryObservation only
Submucosal fibroid (FIGO 0–1)First choiceRarelyRarelyIf you decline surgery
Cavity-distorting intramural >3–4 cmMay work if most of it is inside the cavityCommon choiceIf very large or multipleIf small and quiet
Large symptomatic subserosal fibroidNot suitableFirst choiceIf laparoscopy is not feasibleIf symptoms are mild
Age >38, low ovarian reserveAvoid long delayAvoid long delayRarely preferredStrong option if non-distorting
Wish to start IVF within 1–2 cyclesRemove first if cavity-distortingCase by caseRarelyFine for non-distorting fibroids

Practical planning for international patients

Short answer: If a cavity-distorting fibroid comes out before IVF, plan on roughly four to six weeks before stimulation — enough time to heal and confirm the cavity looks sound.

After hysteroscopic removal, a short stay of a couple of days is common, then a check scan at two to four weeks. IVF can often follow. Laparoscopic removal usually means a few more days in hospital and four to six weeks of recovery, with imaging to confirm the cavity — and to look for adhesions that would matter before transfer.

Bring old ultrasound or MRI reports, and any operative notes you already have. It saves a lot of repeating.

Risks, limits, and when to seek medical advice

Short answer: New heavy bleeding, sudden pelvic pain, or a fibroid that grows quickly should be checked promptly — not to create panic, but to rule out complications or (rarely) something more serious.

See a doctor soon if you notice:

Elective surgery also waits if there is an active pelvic infection, an uncorrected clotting problem, or a pregnancy already underway.

Clinical note

Short answer: Dr. Senai Aksoy: the real question is where the fibroid sits — and surgery does not automatically improve the odds.

Dr. Senai Aksoy: “The question I hear most often isn’t really about whether a fibroid is present — it’s about where it sits. The embryo implants inside the uterine cavity, so even a small fibroid that reaches into the cavity can matter, while a larger one growing outward, leaving the cavity untouched, may not affect the transfer at all.

The second misconception is that surgery always improves the odds. For an intramural fibroid that doesn’t distort the cavity, myomectomy doesn’t reliably improve IVF outcomes — and it can delay treatment by months, with real risks: adhesions, bleeding, scarring in the uterine wall. In an older patient, or one with low ovarian reserve, that delay can matter more than the fibroid itself.

I give patients this example: two women can both have a 4 cm fibroid. One distorts the cavity and needs removal before transfer. The other grows outward and can simply be watched. Same number on the report — not the same fibroid, reproductively speaking.

What bothers me in practice is decisions made on the centimeter alone: ‘over 5 cm, so surgery’ or ‘under 3 cm, so it doesn’t matter.’ Size alone isn’t enough — FIGO type, distance from the endometrium, whether the cavity is distorted, number of fibroids, symptoms, prior transfer history, age, and ovarian reserve all belong in the same conversation.

What I tell patients, in the end: the goal before IVF isn’t a fibroid-free uterus. It’s a healthy cavity the embryo can implant in. Sometimes that means surgery. Sometimes the right call is to leave the fibroid alone and move forward with treatment.”

Questions worth discussing before a decision

Short answer: Bring these to the consultation. They keep the conversation concrete.

Related reading:

FAQ

Do all fibroids reduce fertility?

Short answer: No. Many do not. Location does the heavy lifting.

Smaller subserosal fibroids rarely block pregnancy. Non-distorting intramural ones are still argued over in the literature.

Should every fibroid be removed before IVF?

Short answer: No. Surgery enters the conversation when the cavity is distorted, symptoms are heavy, or implantation looks blocked for a clear mechanical reason.

Evidence supports removing cavity-distorting submucosal fibroids before IVF. Routine removal of quiet intramural fibroids does not have that same backing.

Can intramural fibroids matter even if they are not inside the cavity?

Short answer: Yes — especially when large, or when they deform the lining. Small ones without distortion are the grey zone.

Some studies see worse outcomes above roughly 4–5 cm even without clear distortion. Contractility and the endometrial environment are the usual explanations. The data are not settled.

Are subserosal fibroids usually less important for fertility?

Short answer: Yes. Outward growth usually leaves implantation alone.

Very large ones can still press on a tube or ovary, or hurt enough to need surgery for symptoms alone.

Sources

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.